γδ T cells infiltrated in pancreatic cancer tissues can restrain CD4+ T cell and CD8+ T cell activation by expressing high levels of the immune check point proteins PD-L1 and Galectin-9, thereby negating adaptive anti-tumor immunity [17]. The gene discussed is CD4; the disease is pancreatic neoplasm.